Table 2.
Baseline demographics.
| Characteristic | Full sample (n = 61) | Intervention group (n = 31) | Control group (n = 30) | χ2/Z/t | P |
|---|---|---|---|---|---|
| Age | 36.18 ± 8.51 (22–62) | 36.94 ± 8.45 (22–62) | 35.40 ± 8.64 (23–54) | 0.120 | 0.702a |
| Gender | – | 1.000b | |||
| Male | 60 (98.4) | 30 (96.8) | 30 (100.0) | ||
| Female | 1 (1.6) | 1 (3.2) | 0 (0.0) | ||
| Ethnic groups | – | 0.492b | |||
| Han | 59 (96.7) | 29 (93.5) | 30 (100.0) | ||
| Minority | 2 (3.3) | 2 (6.5) | 0 (0.0) | ||
| Educational attainment | 5.003 | 0.025c | |||
| College or less | 25 (41.0) | 17 (54.8) | 8 (26.7) | ||
| University or above | 36 (59.0) | 14 (45.2) | 22 (73.3) | ||
| Religion | 0.604 | 0.570c | |||
| No | 44 (72.1) | 21 (67.7) | 23 (76.7) | ||
| Yes | 17 (27.9) | 10 (32.3) | 7 (23.3) | ||
| Employment status | – | 1.000b | |||
| Employed | 54 (88.5) | 27 (87.1) | 27 (90.0) | ||
| Unemployed | 2 (3.3) | 1 (3.2) | 1 (3.3) | ||
| Sick leave at home | 2 (3.3) | 1 (3.2) | 1 (3.3) | ||
| Retired | 3 (4.9) | 2 (6.5) | 1 (3.3) | ||
| Household registry | 0.011 | 1.000c | |||
| Shanghai | 37 (60.7) | 19 (61.3) | 18 (60.0) | ||
| Non-shanghai | 24 (39.3) | 12 (38.7) | 12 (40.0) | ||
| Marital status | – | 0.266b | |||
| Single | 50 (82) | 24 (77.4) | 26 (86.7) | ||
| Unmarried with a stable partner | 5 (8.2) | 2 (6.5) | 3 (10.0) | ||
| Widowed | 6 (9.8) | 5 (16.1) | 1 (3.3) | ||
| Monthly income (CNY) | −1.500 | 0.134d | |||
| Less than 5,000 | 12 (19.7) | 9 (29.0) | 3 (10.0) | ||
| 5,000–10,000 | 26 (42.6) | 12 (38.7) | 14 (46.7) | ||
| More than 10,000 | 23 (37.7) | 10 (32.3) | 13 (43.3) | ||
| Months of HIV diagnosis | 25.00 (48.00) | 24.00 (56.00) | 28.50 (39.25) | −0.570 | 0.569d |
| Months of taking ART | 21.00 (33.50) | 16.00 (41.00) | 21.00 (27.75) | −0.368 | 0.713d |
| Latest CD4+ T-cell count (/μl) | −0.168 | 0.866d | |||
| Less than 300 | 19 (31.1) | 9 (29.0) | 10 (33.3) | ||
| 300–500 | 22 (36.1) | 13 (41.9) | 9 (30.0) | ||
| More than 500 | 20 (32.8) | 9 (29.0) | 11 (36.7) | ||
| Latest viral load | 0.137 | 0.772c | |||
| Undetectable | 46 (75.4) | 24 (77.4) | 22 (73.3) | ||
| Detectable | 15 (24.6) | 7 (22.6) | 8 (26.7) | ||
| ART prescription | – | 0.195b | |||
| Free ART | 56 (91.8) | 30 (96.8) | 26 (86.7) | ||
| TDF+3 TC + EFV | 33 (54.1) | 19 (61.3) | 14 (46.7) | ||
| AZT+3 TC + EFV | 7 (11.5) | 3 (9.7) | 4 (13.3) | ||
| ABC+3 TC + EFV | 5 (8.2) | 3 (9.7) | 2 (6.7) | ||
| TDF+3 TC + LPV/r | 3 (4.9) | 1 (3.2) | 2 (6.7) | ||
| AZT+3 TC + LPV/r | 4 (6.6) | 2 (6.5) | 2 (6.7) | ||
| ABC+3 TC + LPV/r | 2 (3.3) | 1 (3.2) | 1 (3.3) | ||
| AZT+3 TC + NVP | 1 (1.6) | 1 (3.2) | 0 (0) | ||
| ABC+3 TC + NVP | 1 (1.6) | 0 (0) | 1 (3.3) | ||
| Self-paying ART | 5 (8.2) | 1 (3.2) | 4 (13.3) | ||
| TDF+3 TC + DTG | 2 (3.3) | 0 (0) | 2 (6.7) | ||
| TDF+3 TC + RAL | 1 (1.6) | 0 (0) | 1 (3.3) | ||
| ABC+3 TC + DTG | 1 (1.6) | 0 (0) | 1 (3.3) | ||
| FTC/TDF + DTG | 1 (1.6) | 1 (3.2) | 0 (0) |
Note: Data are n (%), Median (IQR), or Mean ± SD (range). a independent sample t-test; b Fisher’s exact test; c chi-square test; d Wilcoxon rank-sum test. Free ART in China: TDF, 3TC, EFV, AZT, ABC, LPV/r,NVP. Self-paying ART in China: DTG, RAL, FTC/TDF. ART = antiretroviral therapy. TDF = Tenofovir disoproxil. 3TC = Lamivudine. EFV = Efavurebz. AZT = Zidovudine. ABC = Abacavir. LPV/r = Lopinavir/ritonavir. NVP = Nevirapine. DTG = Dolutegravir. RAL = Raltegravir. FTC/TDF = Emtricitabine/Tenofovir disoproxil.